plerixafor has been researched along with Angiogenesis, Pathologic in 23 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (8.70) | 29.6817 |
2010's | 20 (86.96) | 24.3611 |
2020's | 1 (4.35) | 2.80 |
Authors | Studies |
---|---|
Hu, Z; Ren, H; Wang, P; Zhang, H; Zhang, X; Zhao, W | 1 |
Binner, M; Bornhäuser, M; Bray, LJ; Körner, Y; von Bonin, M; Werner, C | 1 |
Chen, B; Gu, JT; Lu, KZ; Ning, JL; Shen, CC; Yi, B; Zeng, J | 1 |
Dimova, I; Djonov, V; Hlushchuk, R; Karthik, S; Makanya, A; Semela, D; Volarevic, V | 1 |
Anqi, C; Eguchi, T; Kawai, H; Nagatsuka, H; Nakano, K; Okamoto, K; Oo, MW; Sukegawa, S; Takabatake, K; Yoshida, S | 1 |
Fu, J; Liu, J; Shen, J; Sun, D; Wang, X; Xie, Z; Yu, S; Zhang, R | 1 |
Chen, FH; Chiang, CS; Fu, SY; Hong, JH; Wang, CC; Yang, YC | 1 |
Hamdan, R; Kleinerman, ES; Zhou, Z | 1 |
Bai, W; Hu, B; Li, B; Sun, P; Ying, J; Zhou, B | 1 |
Avagliano, L; Beretta, E; Bulfamante, GP; Corbetta, S; Costa, E; Creo, P; Guarnieri, V; Scillitani, A; Soldati, L; Spada, A; Steffano, GB; Verdelli, C; Vicentini, L | 1 |
Boucard, C; Chinot, O; Delfino, C; Denicolai, E; Figarella-Branger, D; Graillon, T; Metellus, P; Nanni, I; Ouafik, L; Padovani, L; Tabouret, E; Tchoghandjian, A | 1 |
Chen, Y; Chern, GG; Chiang, T; Gao, DY; Lin, TT; Liu, CH; Liu, JY | 1 |
Chan, KM; Chen, Y; Chern, GG; Chiang, T; Hsu, FF; Liu, CH; Liu, JY; Liu, YC; Wu, YH | 1 |
Bieche, I; Kieffer, Y; Lefort, S; Marangoni, E; Mechta-Grigoriou, F; Sirven, P; Thuleau, A; Vincent-Salomon, A | 1 |
Cobb, WS; Greenfield, JP; Lyden, D | 1 |
Brown, JM; Harsh, GR; Hoffman, RM; Kioi, M; Schultz, G; Vogel, H | 1 |
Banie, L; Li, LC; Lin, CS; Lin, G; Lue, TF; Ning, H; Wang, G; Yang, R | 1 |
Giebels, C; Laschke, MW; Menger, MD; Nickels, RM; Scheuer, C | 1 |
Bian, XW; Chen, JH; Cui, YH; Jiang, JY; Jiang, T; Lin, MC; Ping, YF; Qian, C; Wang, B; Wang, Jm; Yao, XH; Yu, SC; Zhang, R; Zhao, LT | 1 |
Benayoun, L; Bril, R; Gingis-Velitski, S; Kerbel, RS; Man, S; Milsom, C; Munster, M; Shaked, Y; Voloshin, T | 1 |
Fang, D; Lin, S; Su, N; Sun, L; Yu, B; Yuan, S; Zhou, L | 1 |
Capoccia, BJ; Link, DC; Shepherd, RM | 1 |
Bergers, G; Du, R; Ganss, R; Johnson, RS; Liu, P; Lu, KV; Passegué, E; Petritsch, C; Song, H; Vandenberg, S; Werb, Z | 1 |
23 other study(ies) available for plerixafor and Angiogenesis, Pathologic
Article | Year |
---|---|
SDF1/CXCR4 axis facilitates the angiogenesis via activating the PI3K/AKT pathway in degenerated discs.
Topics: Aged; Benzylamines; Cell Proliferation; Cells, Cultured; Chemokine CXCL12; Coculture Techniques; Cyclams; Endothelial Cells; Female; Heterocyclic Compounds, 3-Ring; Humans; Intervertebral Disc Degeneration; Male; Middle Aged; Neovascularization, Pathologic; Nucleus Pulposus; Phenanthrenes; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Receptors, CXCR4; Signal Transduction | 2020 |
A three-dimensional
Topics: Benzylamines; Biomarkers; Cell Communication; Cell Culture Techniques; Cell Line, Tumor; Cell Movement; Cyclams; Cytarabine; Daunorubicin; Drug Resistance, Neoplasm; Drug Synergism; Heterocyclic Compounds; Humans; Immunophenotyping; Leukemia, Myeloid, Acute; Neovascularization, Pathologic; Receptors, CXCR4; Spheroids, Cellular; Tumor Cells, Cultured; Tumor Microenvironment | 2017 |
AMD3100 treatment attenuates pulmonary angiogenesis by reducing the c-kit (+) cells and its pro-angiogenic activity in CBDL rat lungs.
Topics: Animals; Benzylamines; Cells, Cultured; Common Bile Duct; Cyclams; Down-Regulation; Hepatopulmonary Syndrome; Heterocyclic Compounds; Ligation; Lung; Male; Neovascularization, Pathologic; Proto-Oncogene Proteins c-kit; Rats; Rats, Sprague-Dawley; Signal Transduction | 2018 |
SDF-1/CXCR4 signalling is involved in blood vessel growth and remodelling by intussusception.
Topics: Animals; Benzylamines; Bone Marrow Cells; Cell Adhesion; Chemokine CXCL12; Chick Embryo; Cyclams; Endothelial Cells; Hepatocytes; Heterocyclic Compounds; Intussusception; Leukocytes, Mononuclear; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Microscopy, Electron, Transmission; Neovascularization, Pathologic; Receptor, Notch1; Receptors, CXCR4; Recombinant Proteins; Signal Transduction | 2019 |
Tumor Angiogenic Inhibition Triggered Necrosis (TAITN) in Oral Cancer.
Topics: Adult; Aged; Aged, 80 and over; Animals; Benzylamines; Carcinoma, Squamous Cell; Cell Line, Tumor; Cyclams; Female; Heterocyclic Compounds; Humans; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Middle Aged; Mouth Neoplasms; Neovascularization, Pathologic; Receptors, CXCR4 | 2019 |
Osteoprotegerin (OPG) Promotes Recruitment of Endothelial Progenitor Cells (EPCs) via CXCR4 Signaling Pathway to Improve Bone Defect Repair.
Topics: Angiogenesis Inducing Agents; Animals; Benzylamines; Bone and Bones; Bone Regeneration; Cell Movement; Cells, Cultured; Chemokine CXCL12; Cyclams; Endothelial Progenitor Cells; Heterocyclic Compounds; Humans; Male; Neovascularization, Pathologic; Osteoprotegerin; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Rats; Rats, Sprague-Dawley; Receptors, CXCR4; Signal Transduction; Stem Cells; Vascular Endothelial Growth Factor A | 2019 |
Combination of vessel-targeting agents and fractionated radiation therapy: the role of the SDF-1/CXCR4 pathway.
Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Benzimidazoles; Benzylamines; Bone Marrow Cells; Chemokine CXCL12; Combined Modality Therapy; Cyclams; Dose Fractionation, Radiation; ErbB Receptors; Gefitinib; Green Fluorescent Proteins; Heterocyclic Compounds; Luminescent Agents; Male; Mice; Mice, Inbred C57BL; Neovascularization, Pathologic; Pericytes; Prostatic Neoplasms; Quinazolines; Receptors, CXCR4; Tumor Microenvironment | 2013 |
Blocking SDF-1α/CXCR4 downregulates PDGF-B and inhibits bone marrow-derived pericyte differentiation and tumor vascular expansion in Ewing tumors.
Topics: Animals; Benzylamines; Blotting, Western; Bone Marrow Cells; Bone Marrow Transplantation; Cell Differentiation; Cell Line, Tumor; Cell Survival; Chemokine CXCL12; Cyclams; Down-Regulation; Female; Heterocyclic Compounds; Humans; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Transgenic; Microscopy, Fluorescence; Neovascularization, Pathologic; Pericytes; Proto-Oncogene Proteins c-sis; Receptors, CXCR4; Sarcoma, Ewing; Xenograft Model Antitumor Assays | 2014 |
The effect of CXCL12 on endothelial progenitor cells: potential target for angiogenesis in intracerebral hemorrhage.
Topics: Animals; Antigens, CD; Benzylamines; Cadherins; Cell Adhesion; Cell Differentiation; Cell Movement; Cell Proliferation; Cells, Cultured; Cerebral Hemorrhage; Chemokine CXCL12; Cyclams; Endothelial Cells; Endothelial Progenitor Cells; Heterocyclic Compounds; Male; Neovascularization, Pathologic; Rats; Rats, Sprague-Dawley; Receptor, TIE-2; Receptors, CXCR4; RNA, Messenger; Vascular Remodeling; von Willebrand Factor | 2015 |
Tumour-associated fibroblasts contribute to neoangiogenesis in human parathyroid neoplasia.
Topics: Adenoma; Benzylamines; Coculture Techniques; Cyclams; Fibroblasts; Gene Expression; Gene Expression Regulation, Neoplastic; Heterocyclic Compounds; Humans; Immunohistochemistry; Mesenchymal Stem Cells; Neovascularization, Pathologic; Parathyroid Neoplasms; Signal Transduction; Stromal Cells; Tumor Cells, Cultured; Tumor Microenvironment | 2015 |
Recurrence of glioblastoma after radio-chemotherapy is associated with an angiogenic switch to the CXCL12-CXCR4 pathway.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents, Alkylating; Benzylamines; Brain Neoplasms; Chemokine CXCL12; Chemoradiotherapy; Child; Child, Preschool; Cyclams; Dacarbazine; Disease Progression; Disease-Free Survival; Female; Gene Expression Profiling; Glioblastoma; Heterocyclic Compounds; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Immunohistochemistry; Kaplan-Meier Estimate; Male; Middle Aged; Neoplasm Recurrence, Local; Neovascularization, Pathologic; Proportional Hazards Models; Real-Time Polymerase Chain Reaction; Receptors, CXCR4; Retrospective Studies; Signal Transduction; Temozolomide; Time Factors; Tissue Culture Techniques; Treatment Outcome; Vascular Endothelial Growth Factor Receptor-2; Young Adult | 2015 |
Delivery of siRNA Using CXCR4-targeted Nanoparticles Modulates Tumor Microenvironment and Achieves a Potent Antitumor Response in Liver Cancer.
Topics: Angiogenesis Inhibitors; Animals; Benzylamines; Carcinoma, Hepatocellular; Cell Line, Tumor; Chemokine CXCL12; Cyclams; Disease Progression; Genetic Therapy; Heterocyclic Compounds; Humans; Liver Neoplasms; Male; Mice; Mice, Inbred C3H; Nanoparticles; Neovascularization, Pathologic; Niacinamide; Phenylurea Compounds; Receptors, CXCR4; RNA, Small Interfering; Signal Transduction; Sorafenib; Tumor Microenvironment; Vascular Endothelial Growth Factor A | 2015 |
Dual-Functional Nanoparticles Targeting CXCR4 and Delivering Antiangiogenic siRNA Ameliorate Liver Fibrosis.
Topics: Angiogenesis Inhibitors; Animals; Benzylamines; Carbon Tetrachloride; Carcinoma, Hepatocellular; Cyclams; Disease Models, Animal; Disease Progression; Hepatic Stellate Cells; Heterocyclic Compounds; Humans; Liver; Liver Cirrhosis; Liver Neoplasms; Male; Mice; Mice, Inbred C3H; Nanoparticles; Neovascularization, Pathologic; Receptors, CXCR4; RNA, Small Interfering; Signal Transduction; Vascular Endothelial Growth Factor A | 2016 |
CXCR4 inhibitors could benefit to HER2 but not to triple-negative breast cancer patients.
Topics: Animals; Anti-HIV Agents; Apoptosis; Benzylamines; Biomarkers, Tumor; Breast Neoplasms; Cell Proliferation; Cyclams; Female; Gene Expression Regulation, Neoplastic; Heterocyclic Compounds; Humans; Lung Neoplasms; Mice; Neoplasm Invasiveness; Neovascularization, Pathologic; Peptides; Receptor, ErbB-2; Receptors, CXCR4; Signal Transduction; Triple Negative Breast Neoplasms; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2017 |
Resisting arrest: a switch from angiogenesis to vasculogenesis in recurrent malignant gliomas.
Topics: Animals; Anti-HIV Agents; Antibodies, Neutralizing; Antineoplastic Agents; Benzylamines; Bone Marrow Cells; Brain Neoplasms; CD11b Antigen; Cell Line, Tumor; Cell Movement; Chemokine CXCL12; Cyclams; Glioblastoma; Heterocyclic Compounds; Humans; Hypoxia-Inducible Factor 1; Mice; Mice, Nude; Monocytes; Neoplasm Recurrence, Local; Neoplasm Transplantation; Neovascularization, Pathologic; Receptors, CXCR4; Transplantation, Heterologous; Whole-Body Irradiation | 2010 |
Inhibition of vasculogenesis, but not angiogenesis, prevents the recurrence of glioblastoma after irradiation in mice.
Topics: Animals; Anti-HIV Agents; Antibodies, Neutralizing; Antineoplastic Agents; Benzylamines; Bone Marrow Cells; Brain Neoplasms; CD11b Antigen; Cell Line, Tumor; Cell Movement; Chemokine CXCL12; Cyclams; Glioblastoma; Heterocyclic Compounds; Humans; Hypoxia-Inducible Factor 1; Mice; Mice, Nude; Monocytes; Neoplasm Recurrence, Local; Neoplasm Transplantation; Neovascularization, Pathologic; Receptors, CXCR4; Transplantation, Heterologous; Whole-Body Irradiation | 2010 |
Effects of transplantation of adipose tissue-derived stem cells on prostate tumor.
Topics: Adipose Tissue; Animals; Benzylamines; Cell Movement; Chemokine CXCL12; Cyclams; Fibroblast Growth Factor 2; Heterocyclic Compounds; Male; Mice; Mice, Nude; Microscopy, Fluorescence; Neovascularization, Pathologic; Prostatic Neoplasms; Random Allocation; Receptors, CXCR4; Stem Cell Transplantation; Vascular Endothelial Growth Factor A | 2010 |
Endothelial progenitor cells contribute to the vascularization of endometriotic lesions.
Topics: Animals; Antigens, Ly; Benzylamines; Cyclams; Endometriosis; Endothelium, Vascular; Female; Green Fluorescent Proteins; Heterocyclic Compounds; Membrane Proteins; Mice; Mice, Inbred C57BL; Microvessels; Neovascularization, Pathologic; Stem Cells; Vascular Endothelial Growth Factor Receptor-2 | 2011 |
The chemokine CXCL12 and its receptor CXCR4 promote glioma stem cell-mediated VEGF production and tumour angiogenesis via PI3K/AKT signalling.
Topics: AC133 Antigen; Animals; Antigens, CD; Benzylamines; Cell Transformation, Neoplastic; Chemokine CXCL12; Cyclams; Gene Knockdown Techniques; Glioma; Glycoproteins; Heterocyclic Compounds; Humans; Mice; Mice, SCID; Neoplasm Proteins; Neoplastic Stem Cells; Neovascularization, Pathologic; Peptides; Phosphatidylinositol 3-Kinases; Platelet Endothelial Cell Adhesion Molecule-1; Receptors, CXCR4; RNA, Small Interfering; Signal Transduction; Tumor Stem Cell Assay; Vascular Endothelial Growth Factor A; Xenograft Model Antitumor Assays | 2011 |
G-CSF supplementation with chemotherapy can promote revascularization and subsequent tumor regrowth: prevention by a CXCR4 antagonist.
Topics: Animals; Antineoplastic Agents; Benzylamines; Carcinoma, Lewis Lung; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cyclams; Drug Combinations; Female; Flow Cytometry; Granulocyte Colony-Stimulating Factor; Heterocyclic Compounds; Humans; Immunohistochemistry; Inflammatory Breast Neoplasms; Injections, Intraperitoneal; Matrix Metalloproteinase 2; Mice; Mice, Knockout; Neovascularization, Pathologic; Paclitaxel; Receptors, CXCR4; Vascular Endothelial Growth Factor A; Xenograft Model Antitumor Assays | 2011 |
Vinorelbine inhibits angiogenesis and 95D migration via reducing hypoxic fibroblast stromal cell-derived factor 1 secretion.
Topics: Actins; Animals; Antineoplastic Agents, Phytogenic; Aorta, Thoracic; Benzylamines; Capillaries; Cell Hypoxia; Cell Line, Tumor; Cell Movement; Cell Proliferation; Chemokine CXCL12; Culture Media, Conditioned; Cyclams; Endothelium, Vascular; Heterocyclic Compounds; Human Umbilical Vein Endothelial Cells; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Male; Neoplasm Invasiveness; Neovascularization, Pathologic; Rats; Rats, Sprague-Dawley; Receptors, CXCR4; Stromal Cells; Up-Regulation; Vinblastine; Vinorelbine | 2012 |
G-CSF and AMD3100 mobilize monocytes into the blood that stimulate angiogenesis in vivo through a paracrine mechanism.
Topics: Angiogenesis Inducing Agents; Animals; Benzylamines; CD11b Antigen; Cyclams; Cytokines; Granulocyte Colony-Stimulating Factor; Heterocyclic Compounds; Humans; Mice; Mice, Inbred C57BL; Monocytes; Neovascularization, Pathologic; Paracrine Communication; Receptors, CXCR4 | 2006 |
HIF1alpha induces the recruitment of bone marrow-derived vascular modulatory cells to regulate tumor angiogenesis and invasion.
Topics: Animals; Antigens, Differentiation; Benzylamines; Bone Marrow Cells; Bone Marrow Transplantation; Brain Neoplasms; Cell Hypoxia; Cell Line; Cell Movement; Chemokine CXCL12; Cyclams; Endothelial Cells; Glioblastoma; Heterocyclic Compounds; Hypoxia-Inducible Factor 1, alpha Subunit; Leukocyte Common Antigens; Matrix Metalloproteinase 9; Mice; Mice, Knockout; Monocytes; Neoplasm Invasiveness; Neovascularization, Pathologic; Pericytes; Receptor, TIE-2; Receptors, CXCR4; Signal Transduction; Transduction, Genetic; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-1 | 2008 |